Apimeds Pharmaceuticals US, Inc.

APUS·AMEX·$1.42Share Price as of 11/2·$2MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/26/26 10-KFY 202505/04/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/19/25

Disclosures

8-KCurrent report10/13/26 8-KCurrent report10/01/26 8-KCurrent report09/29/26 8-KCurrent report09/23/26 8-KCurrent report09/11/26

Prospectuses and Registrations

S-8Registration of securities for employees05/23/25 424B4Prospectus05/09/25 POS AMPost-effective amendment05/02/25 POS AMPost-effective amendment05/01/25 POS AMPost-effective amendment04/17/25

Proxies

DEFM14CDEFM14C02/27/26 PREM14CPREM14C01/16/26

Ownership

SC 13D/ABeneficial ownership (amended)05/07/26 SC 13D/ABeneficial ownership (amended)03/30/26 SC 13D/ABeneficial ownership (amended)03/20/26 SC 13GBeneficial ownership02/11/26 SC 13D/ABeneficial ownership (amended)01/26/26

Other

NT 10-QLate filing notification (10-Q)05/15/26 42542504/09/26 NT 10-KLate filing notification (10-K)03/31/26 42542502/17/26 42542512/02/25